News | July 28, 2023
Biocon Foundation releases 2nd edition of consensus guidelines for head & neck cancer
Marks the World Head & Neck Cancer Day at the OCTF Conference
Marks the World Head & Neck Cancer Day at the OCTF Conference
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
_256_384.jpg)
The collaboration aims to raise awareness about eye cancer, provide medical and surgical treatment support to children and supply nutritional supplements to aid in their faster recovery.
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Application being reviewed under the FDA Project Orbis framework, which enables concurrent reviews among US, Australia, Canada, Switzerland, Singapore and United Kingdom health authorities
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
Subscribe To Our Newsletter & Stay Updated
